Aggressive natural killer cell leukemia: Report of a Chinese series and review of the literature

International Journal of Hematology

Volumn 85, Issue 1, 2007, Pages 18-25

  Ryder, John ^a,c   Wang, Xiaoqin ^a,b   Bao, Liming ^a,d   Gross, Sherilyn A ^a,c   Hua, Fu ^a   Irons, Richard D ^a,c  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

CD56; EBV; Leukemia; Natural killer cell

Indexed keywords

CD2 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; LACTATE DEHYDROGENASE; LATENT MEMBRANE PROTEIN 1; STEM CELL FACTOR RECEPTOR; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BONE MARROW; CELL CLONE; CELL DEGENERATION; CHINESE; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE SEVERITY; EPSTEIN BARR VIRUS; ERYTHROPOIESIS; FATALITY; FEMALE; FEVER; GERM LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY DIAGNOSIS; LEUKEMIA; MALE; NATURAL KILLER CELL LEUKEMIA; PATHOGENESIS; PHAGOCYTOSIS; RARE DISEASE; SYSTEMATIC REVIEW; THROMBOCYTOPENIA;

ADULT; AGED; BLOOD CELL COUNT; BONE MARROW DISEASES; CHINA; CYTOGENETIC ANALYSIS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LEUKEMIA, T-CELL; MALE; MIDDLE AGED; THROMBOCYTOPENIA;

EID: 33846677723     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.A10612     Document Type: Article

References (56)

1. Moretta L, Moretta A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J. 2004;23:255-259.
2. Farag SS, VanDeusen JB, Fehniger TA, Caligiuri MA. Biology and clinical impact of human natural killer cells. Int J Hematol. 2003;78:7-17.
3. Spits H, Lanier LL, Phillips JH. Development of human T and natural killer cells. Blood. 1995;85:2654-2670.
4. Jaffe E, Harris N, Stein H, Vardiman J, eds. World Health Organization Classification of Tumours. Pathology & Genetics: Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
5. Oshimi K. Leukemia and lymphoma of natural killer lineage cells. Int J Hematol. 2003;78:18-23.
6. Jaffe ES, Krenacs L, Kumar S, Kingma DW, Raffeld M. Extranodal peripheral T-cell and NK-cell neoplasms. Am J Clin Pathol. 1999;111:S46-S55.
7. + hematodermic neoplasms): a review. Am J Clin Pathol. 2005;123:662-675.
8. Imamura N, Kusunoki Y, Kawa-Ha K, et al. Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells. Br J Haematol. 1990;75:49-59.
9. Quintanilla-Martinez L, Jaffe ES. Commentary: aggressive NK cell lymphomas: insights into the spectrum of NK cell derived malignancies. Histopathology. 2000;37:372-374.
10. Suzuki R, Suzumiya J, Nakamura S, et al. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia. 2004;18:763-770.
11. Mori N, Yamashita Y, Tsuzuki T, et al. Lymphomatous features of aggressive NK cell leukaemia/lymphoma with massive necrosis, haemophagocytosis and EB virus infection. Histopathology. 2000;37:363-371.
12. Kuroda J, Kimura S, Akaogi T, et al. Aggressive natural killer cell leukemia/lymphoma: a comprehensive cytogenetic study by spectral karyotyping. Ann Hematol. 2000;79:519-522.
13. Yagita M, Huang CL, Umehara H, et al. A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation. Leukemia. 2000;14:922-930.
14. Akashi K, Mizuno S. Epstein-Barr virus-infected natural killer cell leukemia. Leuk Lymphoma. 2000;40:57-66.
15. Mizuno S, Akashi K, Ohshima K, et al. Interferon-γ prevents apoptosis in Epstein-Barr virus-infected natural killer cell leukemia in an autocrine fashion. Blood. 1999;93:3494-3504.
16. Takami A, Nakao S, Yachie A, et al. Successful treatment of Epstein-Barr virus-associated natural killer cell large granular lymphocytic leukaemia using allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 1998;21:1279-1282.
17. Kobayashi Y, Uehara S, Inamori K, et al. Hemophagocytosis as a para-neoplastic syndrome in NK cell leukemia. Int J Hematol. 1996;64:135-142.
18. Teshima T, Miyaji R, Fukuda M, Ohshima K. Bone-marrow transplantation for Epstein-Barr-virus-associated natural killer cell-large granular lymphocyte leukaemia. Lancet. 1996;347:1124.
19. Shimodaira S, Ishida F, Kobayashi H, Mahbub B, Kawa-Ha K, Kitano K. The detection of clonal proliferation in granular lymphocyte-proliferative disorders of natural killer cell lineage. Br J Haematol. 1995;90:578-584.
20. Gelb AB, van de Rijn M, Regula DP Jr, et al. Epstein-Barr virus-associated natural killer-large granular lymphocyte leukemia. Hum Pathol. 1994;25:953-960.
21. Kojima H, Suzukawa K, Yatabe Y, Hori M, Nagasawa T, Abe T. Establishment of a new natural killer (NK) cell line, TKS-1, from a patient with aggressive type of large granular lymphocyte (LGL) leukemia. Leukemia. 1994;8:1999-2004.
22. Yatabe Y, Mori N, Hirabayashi N, Asai J. Natural killer cell leukemia: an autopsy case. Arch Pathol Lab Med. 1994;118:1201-1204.
23. Oshimi K, Yamada O, Kaneko T, et al. Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia. 1993;7:782-788.
24. Imashuku S, Okuda T, Yoshihara T, Ikushima S, Hibi S. Cytokine levels in aggressive natural killer cell leukemia and malignant histiocytosis. Br J Haematol. 1991;79:132-133.
25. Okuda T, Sakamoto S, Deguchi T, et al. Hemophagocytic syndrome associated with aggressive natural killer cell leukemia. Am J Hematol. 1991;38:321-323.
26. - large granular lymphocyte leukemia. Am J Hematol. 1990;33:32-38.
27. Ohno Y, Amakawa R, Fukuhara S, et al. Acute transformation of chronic large granular lymphocyte leukemia associated with additional chromosome abnormality. Cancer. 1989;64:63-67.
28. Ohno T, Kanoh T, Arita Y, et al. Fulminant clonal expansion of large granular lymphocytes: characterization of their morphology, phenotype, genotype, and function. Cancer. 1988;62:1918-1927.
29. Kawa-Ha K, Ishihara S, Ninomiya T, et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest. 1989;84:51-55.
30. - surface phenotype: in vitro responsiveness of malignant cells to recombinant human interleukin 2. Blood. 1986;68:1065-1073.
31. Yodoi J, Teshigawara K, Nikaido T, et al. TCGF (IL 2)-receptor inducing factor(s), I: regulation of IL2 receptor on a natural killer-like cell line (YT cells). J Immunol. 1985;134:1623-1630.
32. Song SY, Kim WS, Ko YH, Kim K, Lee MH, Park K. Aggressive natural killer cell leukemia: clinical features and treatment outcome. Haematologica. 2002;87:1343-1345.
33. Chan JK, Sin VC, Wong KF, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood. 1997;89:4501-4513.
34. Wong KF, Chan JK, Kwong YL. Identification of del(6)(q21q25) as a recurring chromosomal abnormality in putative NK cell lymphoma/leukaemia. Br J Haematol. 1997;98:922-926.
35. Kwong YL, Wong KF, Chan LC, et al. Large granular lymphocyte leukemia: a study of nine cases in a Chinese population. Am J Clin Pathol. 1995;103:76-81.
36. Sun T, Schulman P, Kolitz J, et al. A study of lymphoma of large granular lymphocytes with modern modalities: report of two cases and review of the literature. Am J Hematol. 1992;40:135-145.
37. Chan WC, Gu LB, Masih A, et al. Large granular lymphocyte proliferation with the natural killer-cell phenotype. Am J Clin Pathol. 1992;97:353-358.
38. Lin CK, Liu HW, Tse PW, Lai CL, Chan GT. A patient with large granular lymphocytosis of unusual phenotype and polymorphic T-cell receptor beta-chain gene rearrangement. Am J Clin Pathol. 1990;94:211-216.
39. Allory Y, Challine D, Haioun C, et al. Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation: a clinicopathologic study of 11 patients in a Western institution. Am J Surg Pathol. 2001;25:865-874.
40. Mateu R, Badell I, Alcala A, et al. Aggressive natural killer cell leukemia: report of a case in a Caucasian boy. Haematologica. 1998;83:190-192.
41. Dunkley S, Gibson J, Mackinlay N, Joshua D. Aggressive natural killer cell leukemia/lymphoma. Pathology. 1998;30:157-159.
42. Robertson MJ, Cochran KJ, Cameron C, Le JM, Tantravahi R, Ritz J. Characterization of a cell line, NKl, derived from an aggressive human natural killer cell leukemia. Exp Hematol. 1996;24:406-415.
43. + T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood. 1996;87:1466-1473.
44. Nichols GE, Normansell DE, Williams ME. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma. Mod Pathol. 1994;7:819-824.
45. Sun T, Brody J, Susin M, et al. Aggressive natural killer cell lymphoma/leukemia: a recently recognized clinicopathologic entity. Am J Surg Pathol. 1993;17:1289-1299.
46. Hart DN, Baker BW, Inglis MJ, et al. Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells. Blood. 1992;79:2116-2123.
47. Sheridan W, Winton EF, Chan WC, et al. Leukemia of non-T lineage natural killer cells. Blood. 1988;72:1701-1707.
48. Fernandez LA, Pope B, Lee C, Zayed E. Aggressive natural killer cell leukemia in an adult with establishment of an NK cell line. Blood. 1986;67:925-930.
49. Li R, Zhou X, Hao H. One case report of aggressive NK cell leukemia and review of the literature. J Leak Lymphoma. 2004;13:295-297.
50. Zhang X, Hu M, Xu Z. One case report of NK cell large granular lymphocytic leukemia and review of literature. Chin J Pract Int Med. 2003;23:44-46.
51. Pang M, Shi G, Shi N. One case with aggressive NK cell large granular lymphocytic leukemia. Chin J Hematol. 2001;22:48.
52. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257-2317.
53. Sun HS, Su IJ, Lin YC, Chen JS, Fang SY. A 2.6 MB interval on chromosome 6q25.2-q25.3 is commonly deleted in human nasal natural killer/T-cell lymphoma. Br J Haematol. 2003;122:590-599.
54. Wong KF, Zhang YM, Chan JK. Cytogenetic abnormalities in natural killer cell lymphoma/leukaemia: is there a consistent pattern? Leuk Lymphoma. 1999;34:241-250.
55. Siu LL, Wong KF, Chan JK, Kwong YL. Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia: recognition of consistent patterns of genetic alterations. Am J Pathol. 1999;155:1419-1425.
56. Middeldorp JM, Brink AA, van den Brule AJ, Meijer CJ. Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders. Crit Rev Oncol Hematol. 2003;45:1-36.